Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaohui He

Showing results (111-120 of 192) with videos related to

Pageof 20
Sort By:
Journal of Clinical Apheresis|February 3, 2012
Predictive factors for inadequate stem cell mobilization in Chinese patients with NHL and HL: 14-year experience of a single-center studyXiaohong Han, Li Ma, Lingdi Zhao, et al.
The Oncologist|April 7, 2019
Prognostic Nomogram for Overall Survival in Patients with Diffuse Large B-Cell LymphomaYing Han, Jianliang Yang, Peng Liu, et al.
The Journal of Biological Chemistry|May 23, 2021
A20/Nrdp1 interaction alters the inflammatory signaling profile by mediating K48- and K63-linked polyubiquitination of effectors MyD88 and TBK1Zhaoyou Meng, Rui Xu, Lexing Xie, et al.
AMB Express|June 12, 2021
Manipulating the soil microbiomes during a community recovery process with plant beneficial species for the suppression of Fusarium wilt of watermelonXu Zhang, Chao Xue, Dan Fang, et al.
Nature Communications|September 29, 2022
Building up libraries and production line for single atom catalysts with precursor-atomization strategyXiaohui He, Hao Zhang, Xingcong Zhang, et al.
European Journal of Haematology|June 9, 2023
Efficacy and safety of PD-1 monoclonal antibody plus rituximab in relapsed/refractory diffuse large B cell lymphoma patientsYan Qin, Xiaohui He, Xinrui Chen, et al.
Targeted Oncology|April 21, 2024
Deciphering the Prognostic Significance of MYD88 and CD79B Mutations in Diffuse Large B-Cell Lymphoma: Insights into Treatment OutcomesZucheng Xie, Yan Qin, Xinrui Chen, et al.
Nature Communications|August 16, 2019
A versatile route to fabricate single atom catalysts with high chemoselectivity and regioselectivity in hydrogenationXiaohui He, Qian He, Yuchen Deng, et al.
Zhonghua Yi Xue Za Zhi|April 29, 2015
[Clinicopathological features and outcomes: analysis of 21 cases of lymphoma in pregnancy]Lin Gui, Yuankai Shi, Xiaohui He, et al.
Annals of Hematology|July 12, 2017
Intensity-modulated radiation therapy followed by GDP chemotherapy for newly diagnosed stage I/II extranodal natural killer/T cell lymphoma, nasal typeYu Huang, Jianliang Yang, Peng Liu, et al.
Pageof 20

Showing results (111-120 of 192) with videos related to

Sort By:
Pageof 20
Journal of Clinical Apheresis|February 3, 2012
Predictive factors for inadequate stem cell mobilization in Chinese patients with NHL and HL: 14-year experience of a single-center studyXiaohong Han, Li Ma, Lingdi Zhao, et al.
The Oncologist|April 7, 2019
Prognostic Nomogram for Overall Survival in Patients with Diffuse Large B-Cell LymphomaYing Han, Jianliang Yang, Peng Liu, et al.
The Journal of Biological Chemistry|May 23, 2021
A20/Nrdp1 interaction alters the inflammatory signaling profile by mediating K48- and K63-linked polyubiquitination of effectors MyD88 and TBK1Zhaoyou Meng, Rui Xu, Lexing Xie, et al.
AMB Express|June 12, 2021
Manipulating the soil microbiomes during a community recovery process with plant beneficial species for the suppression of Fusarium wilt of watermelonXu Zhang, Chao Xue, Dan Fang, et al.
Nature Communications|September 29, 2022
Building up libraries and production line for single atom catalysts with precursor-atomization strategyXiaohui He, Hao Zhang, Xingcong Zhang, et al.
European Journal of Haematology|June 9, 2023
Efficacy and safety of PD-1 monoclonal antibody plus rituximab in relapsed/refractory diffuse large B cell lymphoma patientsYan Qin, Xiaohui He, Xinrui Chen, et al.
Targeted Oncology|April 21, 2024
Deciphering the Prognostic Significance of MYD88 and CD79B Mutations in Diffuse Large B-Cell Lymphoma: Insights into Treatment OutcomesZucheng Xie, Yan Qin, Xinrui Chen, et al.
Nature Communications|August 16, 2019
A versatile route to fabricate single atom catalysts with high chemoselectivity and regioselectivity in hydrogenationXiaohui He, Qian He, Yuchen Deng, et al.
Zhonghua Yi Xue Za Zhi|April 29, 2015
[Clinicopathological features and outcomes: analysis of 21 cases of lymphoma in pregnancy]Lin Gui, Yuankai Shi, Xiaohui He, et al.
Annals of Hematology|July 12, 2017
Intensity-modulated radiation therapy followed by GDP chemotherapy for newly diagnosed stage I/II extranodal natural killer/T cell lymphoma, nasal typeYu Huang, Jianliang Yang, Peng Liu, et al.
Pageof 20